Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

It’s official: Embecta Corp. is now one of the largest pure-play diabetes management companies worldwide. On April 1, Franklin Lakes-based BD announced it completed the spinoff of its former Diabetes ...

After spinning out its diabetes business into a separate company last quarter, BD said it would move forward as a more agile, yet stable organization, with a stronger focus on the types of hardware ...

Under the transaction terms, BD shareholders received one share of Embecta stock for every five shares of BD that they held as of March 22. The Embecta spinoff severs all financial ties to BD, which ...

BD, a leading global medical technology company, recently announced that its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta. The ...

FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the ...

Serving as the CEO of a freshly established medical technology company comes with its fair share of stress, but there’s an extra layer of pressure when that new company comprises a business with a ...

Over 2,000 employees globally serving more than 100 countries. FRANKLIN LAKES, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) and its employees around the world ...

Record date for spin-off is March 22, 2022 'When Issued' trading of embecta common stock is expected to begin on March 21, 2022, under the ticker 'EMBCV' BD expects the spin-off of embecta to be ...

FRANKLIN LAKES, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) and its employees around the world celebrate its launch today as one of the largest global pure-play ...

FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced its board of directors has approved the ...